US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

PURPOSE: Four US National Clinical Trials Network components (Southwest Oncology Group, Cancer and Leukemia Group B/Alliance, Eastern Cooperative Oncology Group, and the AIDS Malignancy Consortium) conducted a phase II Intergroup clinical trial that used early interim fluorodeoxyglucose positron emi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Oncol
Main Authors: Press, Oliver W., Li, Hongli, Schöder, Heiko, Straus, David J., Moskowitz, Craig H., LeBlanc, Michael, Rimsza, Lisa M., Bartlett, Nancy L., Evens, Andrew M., Mittra, Erik S., LaCasce, Ann S., Sweetenham, John W., Barr, Paul M., Fanale, Michelle A., Knopp, Michael V., Noy, Ariela, Hsi, Eric D., Cook, James R., Lechowicz, Mary Jo, Gascoyne, Randy D., Leonard, John P., Kahl, Brad S., Cheson, Bruce D., Fisher, Richard I., Friedberg, Jonathan W.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2016
נושאים:
ORIGINAL REPORTS
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966513/
https://ncbi.nlm.nih.gov/pubmed/27069074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.63.1119
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים